Suven Pharmaceuticals Limited (BOM: 543064)
India
· Delayed Price · Currency is INR 1,078.70
+8.60 (0.80%)
At close: Jan 17, 2025
Suven Pharmaceuticals Revenue
Suven Pharmaceuticals had revenue of 2.58B INR in the quarter ending September 30, 2024, with 11.54% growth. This brings the company's revenue in the last twelve months to 9.61B, down -26.16% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.
Revenue (ttm)
9.61B
Revenue Growth
-26.16%
P/S Ratio
n/a
Revenue / Employee
8.06M
Employees
1,193
Market Cap
268.24B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,761.06B |
| Bharti Airtel | 1,554.78B |
| ICICI Bank | 1,638.51B |
| Infosys | 1,635.60B |
| State Bank of India | 3,360.28B |
| ITC Limited | 751.35B |